VSTM

Verastem, Inc.

$4.19 -3.23%

Recent alerts on VSTM

All signals →

SEC filing VSTM Elects 3 Class II Directors, Approves Amended 2021 & 2018 Equity Plans, Ratifies Ernst & Young, Passes Say-on-Pay Vote

News Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

News Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)

News Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

News Verastem outlines cash runway into the first half of 2027 while targeting LGSOC self-sustainability in the second half of 2026

News Verastem Non-GAAP EPS of -$0.43 beats by $0.04, revenue of $18.67M misses by $2.72M

Insider trade Sale by Dan Paterson (President and CEO)

Short volume Short volume 72% of volume (4.6σ)

News Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2

News Verastem GAAP EPS of -$0.50 beats by $0.02, revenue of $17.54M beats by $0.7M

SEC filing VSTM Reports $0 Revenue, $0 EPS, RAS/MAPK Therapy Pipeline, $150M Funding Risk, FDA Approval Uncertainty

News Quant snapshot: Impala Platinum, Turkcell Iletisim lead strong buys as Evolus lag

News Earnings week ahead: AVGO, CRWD, PLUG, COST, TGT, MRVL, JD, KR, and more

Insider trade Sale by Dan Paterson (President and CEO)

Insider trade Sale by Dan Paterson

Insider trade Sale by Daniel Calkins

News Hair Loss Biopharma Firm Veradermics Raises $256 Million in IPO

News Veradermics Files for Initial Public Offering to Fund Hair-Growth Pill

News Immuneering plummets following phase 2 data of atebimetinib for pancreatic cancer

News Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Scanner Unusual volume (z=4.1)

Scanner Unusual volume (z=4.3)

Scanner Unusual volume (z=4.3)

Scanner Unusual volume (z=4.3)

Get push alerts for VSTM

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS